![]() |
Volumn 34, Issue 1, 2009, Pages 249-250
|
Targeting AMPA and kainate receptors in neurological disease: Therapies on the horizon?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID;
6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE;
AMPA RECEPTOR;
AMPA RECEPTOR AGONIST;
AMPA RECEPTOR ANTAGONIST;
CX 717;
IONOTROPIC RECEPTOR;
KAINIC ACID RECEPTOR;
KAINIC ACID RECEPTOR ANTAGONIST;
LY 415395;
NGX 424;
PERAMPANEL;
TALAMPANEL;
TEZAMPANEL;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
AMYOTROPHIC LATERAL SCLEROSIS;
ANALGESIC ACTIVITY;
ATTENTION DEFICIT DISORDER;
CLINICAL TRIAL;
COGNITION;
COMPLEX PARTIAL SEIZURE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SYNTHESIS;
DRUG TARGETING;
EPILEPTIC STATE;
GLIOBLASTOMA;
HUMAN;
MIGRAINE;
NERVE CELL PLASTICITY;
NERVE DEGENERATION;
NERVE EXCITABILITY;
NEUROLOGIC DISEASE;
NEUROPATHIC PAIN;
NEUROTRANSMISSION;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
RESPIRATION DEPRESSION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANIMALS;
DRUG DELIVERY SYSTEMS;
HUMANS;
NERVOUS SYSTEM DISEASES;
RECEPTORS, AMPA;
RECEPTORS, KAINIC ACID;
|
EID: 57649121628
PISSN: 0893133X
EISSN: None
Source Type: Journal
DOI: 10.1038/npp.2008.158 Document Type: Short Survey |
Times cited : (37)
|
References (5)
|